1-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairment

André Faldt; Heidi Lopez De Diego; Rene Holm

1-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairment

André Faldt (Opfinder), Heidi Lopez De Diego (Opfinder), Rene Holm (Opfinder)

Publikation: Patent

Abstrakt

1-[2-(2,4-dimethylphenylsulphanyl)phenyl)]piperazine exhibits potent activity on SERT, 5-HT3 and 5-HT1A and may as such be useful for the treatment of cognitive impairment, especially in depressed patients.

Originalsprog	Engelsk
IPC	C07D 295/ 096 A I
Patentnummer	US2017360777
Land/Område	Danmark
Prioritetsdato	10/08/2017
Prioritetsnummer	US201715674043
Status	Udgivet - 21. dec. 2017
Udgivet eksternt	Ja

Citationsformater

@misc{4374ce7d0436465a8c0f02430fb45aad,

title = "1-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairment",

abstract = "1-[2-(2,4-dimethylphenylsulphanyl)phenyl)]piperazine exhibits potent activity on SERT, 5-HT3 and 5-HT1A and may as such be useful for the treatment of cognitive impairment, especially in depressed patients.",

author = "Andr{\'e} Faldt and {De Diego}, {Heidi Lopez} and Rene Holm",

year = "2017",

month = dec,

day = "21",

language = "English",

type = "Patent",

note = "US2017360777; C07D 295/ 096 A I",

}

TY - PAT

T1 - 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairment

AU - Faldt, André

AU - De Diego, Heidi Lopez

AU - Holm, Rene

PY - 2017/12/21

Y1 - 2017/12/21

N2 - 1-[2-(2,4-dimethylphenylsulphanyl)phenyl)]piperazine exhibits potent activity on SERT, 5-HT3 and 5-HT1A and may as such be useful for the treatment of cognitive impairment, especially in depressed patients.

AB - 1-[2-(2,4-dimethylphenylsulphanyl)phenyl)]piperazine exhibits potent activity on SERT, 5-HT3 and 5-HT1A and may as such be useful for the treatment of cognitive impairment, especially in depressed patients.

M3 - Patent

M1 - US2017360777

ER -

1-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairment

Abstrakt

Fingeraftryk

Citationsformater